Algorithms to predict cerebral malaria in murine models using the SHIRPA protocol

Malaria Journal

Volumn 9, Issue 1, 2010, Pages

  Martins, Yuri C ^a   Werneck, Guilherme L ^a   Carvalho, Leonardo J ^a,c   Silva, Beatriz P T ^a   Andrade, Bruno G ^a   Souza, Tadeu M ^b   Souza, Diogo O ^b   Daniel Ribeiro, Cláudio T ^a  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^c LA JOLLA BIOENGINEERING INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALGORITHM; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN MALARIA; CONTROLLED STUDY; FEMALE; INCIDENCE; MOUSE; MURINAE; NONHUMAN; PARASITEMIA; PERFORMANCE; PLASMODIUM BERGHEI; PREDICTION; REPRODUCIBILITY; SCREENING; SHIRPA; TIME OF DEATH; ANIMAL; ANIMAL BEHAVIOR; C57BL MOUSE; DISEASE MODEL; FORECASTING; GENETICS; MALARIA; NEUROLOGIC DISEASE; NEUROLOGIC EXAMINATION; NEUROPSYCHOLOGICAL TEST; PARASITOLOGY; PATHOGENICITY; PATHOLOGY; PHYSIOLOGY; STATISTICAL MODEL;

ALGORITHMS; ANIMALS; BEHAVIOR, ANIMAL; DISEASE MODELS, ANIMAL; FEMALE; FORECASTING; LOGISTIC MODELS; MALARIA, CEREBRAL; MICE; MICE, INBRED C57BL; NERVOUS SYSTEM DISEASES; NEUROLOGIC EXAMINATION; NEUROPSYCHOLOGICAL TESTS; PLASMODIUM BERGHEI;

EID: 77950656248     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/1475-2875-9-85     Document Type: Article

References (41)

1. Cerebral malaria in children is associated with long-term cognitive impairment. CC John P Bangirana J Byarugaba RO Opoka R Idro AM Jurek B Wu MJ Boivin, Pediatrics 2008 122 92 99
2. Strain theory of malaria: the first 50 years. FE McKenzie DL Smith WP O'Meara EM Riley, Adv Parasitol 2008 66 1 46
3. Pathogenesis, clinical features, and neurological outcome of cerebral malaria. R Idro NE Jenkins CR Newton, Lancet Neurol 2005 4 827 840
4. Immunopathogenesis of cerebral malaria. NH Hunt J Golenser T Chan-Ling S Parekh C Rae S Potter IM Medana J Miu HJ Ball, Int J Parasitol 2006 36 569 582
5. High prevalence of asymptomatic Plasmodium vivax and Plasmodium falciparum infections in native Amazonian populations. FP Alves RR Durlacher MJ Menezes H Krieger LH Silva EP Camargo, Am J Trop Med Hyg 2002 66 641 648
6. Short report: severe malaria associated with blood group. PR Fischer P Boone, Am J Trop Med Hyg 1998 58 122 123
7. Malaria parasitemia in healthy Africans in North Mara, Tanzania. PJ Imperato, J Community Health 1986 11 92 97
8. Scanning electron microscopy of the neuropathology of murine cerebral malaria. P Lackner R Beer R Helbok G Broessner K Engelhardt C Brenneis E Schmutzhard K Pfaller, Malar J 2006 5 116
9. Matrix metalloproteinases and their tissue inhibitors (TIMPs) in Plasmodium falciparum malaria: serum levels of TIMP-1 are associated with disease severity. A Dietmann R Helbok P Lackner S Issifou B Lell PB Matsiegui M Reindl E Schmutzhard PG Kremsner, J Infect Dis 2008 197
10. A profound alteration of blood TCRB repertoire allows prediction of cerebral malaria. A Collette S Bagot ME Ferrandiz PA Cazenave A Six S Pied, J Immunol 2004 173 4568 4575
11. Cytokines: accelerators and brakes in the pathogenesis of cerebral malaria. NH Hunt GE Grau, Trends Immunol 2003 24 491 499
12. L3T4+ T lymphocytes play a major role in the pathogenesis of murine cerebral malaria. GE Grau PF Piguet HD Engers JA Louis P Vassalli PH Lambert, J Immunol 1986 137 2348 2354
13. Pathology of fatal and resolving Plasmodium berghei cerebral malaria in mice. AL Neill NH Hunt, Parasitology 1992 105 165 175
14. Cerebral malaria in inbred mice. I. A new model and its pathology. JR Rest, Trans R Soc Trop Med Hyg 1982 76 410 415
15. Cerebral malaria: the contribution of studies in animal models to our understanding of immunopathogenesis. JB de Souza EM Riley, Microbes Infect 2002 4 291 300
16. Pathogenesis of cerebral malaria: recent experimental data and possible applications for humans. J Lou R Lucas GE Grau, Clin Microbiol Rev 2001 14 810 820
17. Identification of two cerebral malaria resistance loci using an inbred wild-derived mouse strain. S Bagot S Campino C Penha-Goncalves S Pied PA Cazenave D Holmberg, Proc Natl Acad Sci USA 2002 99 9919 9923
18. Inhibition of histamine-mediated signaling confers significant protection against severe malaria in mouse models of disease. W Beghdadi A Porcherie BS Schneider D Dubayle R Peronet M Huerre T Watanabe H Ohtsu J Louis S Mecheri, J Exp Med 2008 205 395 408
19. Matrix metalloproteinases, tissue inhibitors of MMPs and TACE in experimental cerebral malaria. PE Van den Steen I Van Aelst S Starckx K Maskos G Opdenakker A Pagenstecher, Lab Invest 2006 86 873 888
20. Cloned lines of Plasmodium berghei ANKA differ in their abilities to induce experimental cerebral malaria. V Amani MI Boubou S Pied M Marussig D Walliker D Mazier L Renia, Infect Immun 1998 66 4093 4099
21. Immunological aspects of cerebral lesions in murine malaria. JH Curfs TP Schetters CC Hermsen CR Jerusalem AA van Zon WM Eling, Clin Exp Immunol 1989 75 136 140
22. Characterization of cerebral malaria in the outbred Swiss Webster mouse infected by Plasmodium berghei ANKA. YC Martins MJ Smith M Pelajo-Machado GL Werneck HL Lenzi CT Daniel-Ribeiro LJ Carvalho, Int J Exp Pathol 2009 90 119 130
23. Cyclooxygenase-2 in the pathogenesis of murine cerebral malaria. HJ Ball HG MacDougall IS McGregor NH Hunt, J Infect Dis 2004 189 751 758
24. Behavioural and histopathological alterations in mice with cerebral malaria. P Lackner R Beer V Heussler G Goebel D Rudzki R Helbok E Tannich E Schmutzhard, Neuropathol Appl Neurobiol 2006 32 177 188
25. Behavioral and functional analysis of mouse phenotype: SHIRPA, a proposed protocol for comprehensive phenotype assessment. DC Rogers EM Fisher SD Brown J Peters AJ Hunter JE Martin, Mamm Genome 1997 8 711 713
26. Development of SHIRPA to characterise the phenotype of gene-targeted mice. JP Hatcher DN Jones DC Rogers PD Hatcher C Reavill JJ Hagan AJ Hunter, Behav Brain Res 2001 125 43 47
27. Prognostic factors in meningococcal disease. Development of a bedside predictive model and scoring system. Barcelona Meningococcal Disease Surveillance Group. N Barquet P Domingo JA Cayla J Gonzalez C Rodrigo P Fernandez-Viladrich FA Moraga-Llop F Marco J Vazquez JA Saez-Nieto J Casal J Canela M Foz, JAMA 1997 278 491 496
28. Crossval. A macro for Stata. http://www.biostat.jhsph.edu/ejohnson/ regression/crossval.ado
29. Reliability, robustness, and reproducibility in mouse behavioral phenotyping: a cross-laboratory study. S Mandillo V Tucci SM Holter H Meziane MA Banchaabouchi M Kallnik HV Lad PM Nolan AM Ouagazzal EL Coghill K Gale E Golini S Jacquot W Krezel A Parker F Riet I Schneider D Marazziti J Auwerx SD Brown P Chambon N Rosenthal G Tocchini-Valentini W Wurst, Physiol Genomics 2008 34 243 255
30. SHIRPA, a protocol for behavioral assessment: validation for longitudinal study of neurological dysfunction in mice. DC Rogers J Peters JE Martin S Ball SJ Nicholson AS Witherden M Hafezparast J Latcham TL Robinson CA Quilter EM Fisher, Neurosci Lett 2001 306 89 92
31. The behavioural effect of middle cerebral artery occlusion on apolipoprotein-E deficient mice. JP Hatcher D Virley SJ Hadingham J Roberts AJ Hunter AA Parsons, Behav Brain Res 2002 131 139 149
32. Functional assessments in mice and rats after focal stroke. AJ Hunter J Hatcher D Virley P Nelson E Irving SJ Hadingham AA Parsons, Neuropharmacology 2000 39 806 816
33. Developmental vitamin D deficiency alters adult behaviour in 129/SvJ and C57BL/6J mice. LR Harms DW Eyles JJ McGrath A Mackay-Sim TH Burne, Behav Brain Res 2008 187 343 350
34. Radiolabeled melanin-binding peptides are safe and effective in treatment of human pigmented melanoma in a mouse model of disease. E Dadachova T Moadel AD Schweitzer RA Bryan T Zhang L Mints E Revskaya X Huang G Ortiz JS Nosanchuk JD Nosanchuk A Casadevall, Cancer Biother Radiopharm 2006 21 117 129
35. Behavioural profiling of a murine Charcot-Marie-Tooth disease type 1A model. JC Norreel M Jamon G Riviere E Passage M Fontes F Clarac, Eur J Neurosci 2001 13 1625 1634
36. Testing of SHIRPA, a mouse phenotypic assessment protocol, on Dmd(mdx) and Dmd(mdx3cv) dystrophin-deficient mice. JA Rafael Y Nitta J Peters KE Davies, Mamm Genome 2000 11 725 728
37. Plasmodium berghei: cerebral malaria in CBA mice is not clearly related to plasma TNF levels or intensity of histopathological changes. LJ Carvalho HL Lenzi M Pelajo-Machado DN Oliveira CT Daniel-Ribeiro MF Ferreira-da-Cruz, Exp Parasitol 2000 95 1 7
38. The origins and uses of mouse outbred stocks. R Chia F Achilli MF Festing EM Fisher, Nat Genet 2005 37 1181 1186
39. The Bradford Hill considerations on causality: a counterfactual perspective. M Hofler, Emerg Themes Epidemiol 2005 2 11
40. In-depth validation of acridine orange staining for flow cytometric parasite and reticulocyte enumeration in an experimental model using Plasmodium berghei. L Hein-Kristensen L Wiese JA Kurtzhals T Staalsoe, Exp Parasitol 2009 123 152 157
41. Murine Cerebral Malaria Is Associated with a Vasospasm-Like Microcirculatory Dysfunction, and Survival upon Rescue Treatment Is Markedly Increased by Nimodipine. P Cabrales GM Zanini D Meays JA Frangos LJ Carvalho, Am J Pathol 2010 176 1306 1315